Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details)

v3.23.1
INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]      
Total revenues $ 66,925 $ 46,169  
Operating and other expenses (11,970) (8,480)  
Depreciation and amortization (23,876) (18,838)  
Interest expense (22,014) (11,606)  
Net loss (16,230) $ (4,527)  
Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Schedule of Equity Method Investments [Line Items]      
Total revenues 21,825   $ 36,127
Operating and other expenses (8,444)   (25,499)
Depreciation and amortization (5,565)   (6,560)
Interest expense (7,713)   (6,776)
Net loss $ 103   $ (2,708)